Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilocarpine for Radiation-Induced Oral Complications
NCT00003139Phase 3Completed
- Sponsor
- NRG Oncology
- Start
- Mar 1998
- Primary completion
- Jan 2001
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in radiation-induced xerostomia and radiation-induced mucositis (RIOM) comparing Pilocarpine with Placebo (2 arms). Primary endpoint: Acute salivary gland toxicity at 13 weeks. Started Mar 1998; status: completed.
02
Drugs
pilocarpine
03
Conditions
radiation-induced xerostomiaradiation-induced mucositis (RIOM)
Beyond the preview
Go deeper on NCT00003139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003139.